And thats why the Chief Medical Officer was appointed... hoping for a smooth outcome for the remainder of the trial/phase II and Phase III.
Ann: ACCENT Trial Achieves Superiority over Chemotherapy Alone, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.005(2.13%) |
Mkt cap ! $110.6M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 22.5¢ | $1.059M | 4.549M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 102503 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 537539 | 8 |
View Market Depth
| Last trade - 11.05am 30/07/2025 (20 minute delay) ? |
| ATX (ASX) Chart |